Interaction of Lymphocytes with Mesenchymal Stem Cells

[1]  F. Barry,et al.  Donor-derived equine mesenchymal stem cells suppress proliferation of mismatched lymphocytes. , 2016, Equine veterinary journal.

[2]  Fatemeh Alikarami,et al.  The Immunosuppressive Activity of Amniotic Membrane Mesenchymal Stem Cells on T Lymphocytes , 2015, Avicenna journal of medical biotechnology.

[3]  Yan Li,et al.  [Human amniotic mesenchymal stem cells inhibit allogeneic lymphocyte proliferation and reduce the secretion of interferon γ]. , 2015, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology.

[4]  M. Stojkovic,et al.  Mesenchymal Stem Cells: A Friend or Foe in Immune-Mediated Diseases , 2015, Stem Cell Reviews and Reports.

[5]  G. Sukhikh,et al.  Mesenchymal Stem Cells from Human Dental Pulp: Isolation, Characteristics, and Potencies of Targeted Differentiation , 2014, Bulletin of Experimental Biology and Medicine.

[6]  P. Ran,et al.  Mesenchymal stem cells suppress T cells by inducing apoptosis and through PD-1/B7-H1 interactions. , 2014, Immunology letters.

[7]  B. Hashemi-beni,et al.  The effect of stem cell from human exfoliated deciduous teeth on T lymphocyte proliferation , 2014, Advanced biomedical research.

[8]  Dong Li,et al.  [Immunosuppressive effects of fetal bone marrow derived mesenchymal stem cells on in vitro proliferation of adult peripheral lymphocyte and expression of immune-related factors]. , 2014, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

[9]  H. Yoon,et al.  B7-H1 inhibits T cell proliferation through MHC class II in human mesenchymal stem cells. , 2014, Transplantation proceedings.

[10]  F. Casiraghi,et al.  Assessment of anti-donor T cell proliferation and cytotoxic T lymphocyte-mediated lympholysis in living donor kidney transplant patients. , 2014, Methods in molecular biology.

[11]  M. Toungouz,et al.  Erratum to: Immune-Related Antigens, Surface Molecules and Regulatory Factors in Human-Derived Mesenchymal Stromal Cells: The Expression and Impact of Inflammatory Priming , 2012, Stem Cell Reviews and Reports.

[12]  M. Toungouz,et al.  Immune-Related Antigens, Surface Molecules and Regulatory Factors in Human-Derived Mesenchymal Stromal Cells: The Expression and Impact of Inflammatory Priming , 2012, Stem Cell Reviews and Reports.

[13]  X. Sui,et al.  Immune characterization of mesenchymal stem cells in human umbilical cord Wharton's jelly and derived cartilage cells. , 2012, Cellular immunology.

[14]  Jie Chen,et al.  Comparison of human amniotic fluid-derived and umbilical cord Wharton's Jelly-derived mesenchymal stromal cells: Characterization and myocardial differentiation capacity , 2012, Journal of geriatric cardiology : JGC.

[15]  P. Rameshwar.  Current thoughts on the therapeutic potential of stem cell. , 2012, Methods in molecular biology.

[16]  J. Briones,et al.  T-Cell Costimulatory Molecules in Acute-Graft-Versus Host Disease: Therapeutic Implications , 2010, Bone marrow research.

[17]  S. Galimberti,et al.  Mesenchymal cells inhibit expansion but not cytotoxicity exerted by gamma–delta T cells , 2009, European journal of clinical investigation.

[18]  R. Ramasamy,et al.  The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function. , 2008, Cellular immunology.

[19]  Sergio Romagnani,et al.  Role for Interferon‐γ in the Immunomodulatory Activity of Human Bone Marrow Mesenchymal Stem Cells , 2006 .

[20]  Sergio Romagnani,et al.  Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. , 2006, Stem cells.

[21]  G. Mancardi,et al.  Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. , 2005, Blood.

[22]  O. Koç,et al.  Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells. , 2005, Experimental hematology.

[23]  E. Lam,et al.  Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. , 2005, Blood.

[24]  J. Mosca,et al.  T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. , 2005, Journal of biomedical science.

[25]  O. Ringdén,et al.  Mesenchymal Stem Cells Inhibit the Expression of CD25 (Interleukin‐2 Receptor) and CD38 on Phytohaemagglutinin‐Activated Lymphocytes , 2004, Scandinavian journal of immunology.

[26]  G. Sukhikh,et al.  Neural Stem and Progenitor Cells of Human Embryos and Fetuses as a Basis of New Biomedical Technologies , 2003, Russian Journal of Developmental Biology.

[27]  O. Ringdén,et al.  Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells , 2003, Transplantation.

[28]  E. Guinan,et al.  Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation , 2003, Transplantation.

[29]  O. Ringdén,et al.  Mesenchymal Stem Cells Inhibit and Stimulate Mixed Lymphocyte Cultures and Mitogenic Responses Independently of the Major Histocompatibility Complex , 2003, Scandinavian journal of immunology.

[30]  C. Carlo-Stella,et al.  Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. , 2002, Blood.

[31]  A. B. Lyons,et al.  Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. , 2000, Journal of immunological methods.